INOVIO PHARMACEUTICALS, INC. (NASDAQ:INO) filed a Form 8-K with the Securities and Exchange Commission on January 27, 2026, disclosing a material event.
INOVIO PHARMACEUTICALS, INC.'s stock currently trades at $1.53 with a market capitalization of $114.7M. The Healthcare company's stock moved following the disclosure.